ByTrending Posts
How Unlearn AI and APST Research Are Revolutionizing…
December 11, 2024 Enhancing Phase II and III Trials by Increasing Statistical Power and Reducing Sample Sizes Unlearn,…
Can BigHat and Johnson & Johnson’s AI-Driven Antibody…
Key Takeaways A Strategic Leap: BigHat Joins Forces with Johnson & Johnson for Neuroscience InnovationBigHat Biosciences, known for…
Endoscopic AI: How Are Medtronic & Cosmo Pharmaceuticals…
Dublin, Ireland – April 12, 2024 — Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) and Medtronic plc (NYSE:…
PostEra and Pfizer’s AI Lab Accelerates Drug Discovery,…
Boston – March 27, 2024 Advancing AI-Driven Drug Discovery PostEra has provided an update on the progress of…
BenevolentAI Reports Positive Phase Ia Results for AI-Designed…
London, UK – March 25, 2024 Clinical Milestone Achieved BenevolentAI has announced positive safety results from its Phase…
Relation Therapeutics Secures $35 Million in New Seed…
London, UK – March 14, 2024 Relation Therapeutics, a biotechnology company at the forefront of computational and experimental…
Saama and Pfizer Deepen AI Partnership to Accelerate…
Expanded multi-year agreement will scale AI-powered data solutions across Pfizer’s R&D portfolio. Campbell, CA – February 12, 2024…
Cervical Cancer Detection AI: How Is BD Applying…
BD and Techcyte Partner on AI-Based Application to Modernize Cervical Cancer Screening FRANKLIN LAKES, N.J. & OREM, Utah…
Merck and Variational AI Collaborate to Advance AI-Driven…
Vancouver, BC – January 25, 2024 Variational AI, a leader in generative AI drug discovery, has announced a…
Trending Posts
Latest Stories
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital…
Is McRae Tech Setting a New Standard for Scalable AI in Healthcare with Its Orchestral Platform?
McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale,…
Is Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma in Japan?
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan…
Gallery
